Arabic Arabic English English French French German German
dark

Carb-X announces up to $13.8m funding for STIs diagnostic

CARB-X is awarding Novel Microdevices, of Baltimore, up to $3.6 million in non-dilutive funding, and, up to an additional $10.2 million if certain project milestones are met, to develop a new rapid molecular test to diagnose STIs. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

An amyloid link between Parkinson’s disease and melanoma

Next Post

Time to build a fairer, healthier world

Related Posts
Total
0
Share